Aptahem to host investor webinar on Apta-1 clinical development strategy

PUBT · 1d ago
Aptahem to host investor webinar on Apta-1 clinical development strategy
  • Aptahem will host an investor webinar on Sept. 28, 2026, from 19:00 to 20:00 local time.
  • CEO Mikael Lindstam will outline the clinical development strategy for Apta-1.
  • Update to cover partnering efforts for Apta-1, alongside the ongoing rights issue of units.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptahem AB published the original content used to generate this news brief via Cision (Ref. ID: 202609220230BITN____UKPR__SV_20260921-BIT-3472-0) on September 22, 2026, and is solely responsible for the information contained therein.